Skip to content
PubMed This is a summary of 54 peer-reviewed journal articles Updated
Neurology

Central Nervous System (CNS) Vasculitis: A Patient Guide

At a Glance

CNS vasculitis is inflammation of blood vessels in the brain and spinal cord. Doctors often combine MRI, spinal fluid analysis, blood-vessel imaging, and sometimes brain biopsy to diagnose it, then use intensive induction medicines followed by long-term maintenance and relapse monitoring.

Central Nervous System (CNS) vasculitis is a rare and serious condition characterized by inflammation of the blood vessels within the brain and spinal cord. While this inflammation can sometimes occur as a secondary complication of other systemic diseases, Primary Angiitis of the Central Nervous System (PACNS) is a unique form where the suspected immune system’s attack is restricted solely to the neurological vessels [1][2]. Because the disease is so uncommon, many patients endure a prolonged diagnostic journey, moving through various specialists and tests before finally arriving at an answer. Validating this journey is an important first step in your care, as it acknowledges the persistence required to identify a condition that many local clinics may have limited experience with [3][4].

The disease behaves unpredictably because it can affect vessels of different sizes in various regions of the brain. For some, the symptoms develop slowly as subtle cognitive changes, persistent headaches, or a general sense of “brain fog” [5]. For others, the condition may present more abruptly with focal, stroke-like episodes such as sudden weakness or difficulty speaking [6]. This wide variation in how the disease looks on the outside is why doctors must use a multimodal diagnostic approach on the inside, typically combining advanced MRI imaging and spinal fluid analysis with specialized procedures like catheter angiography or a brain biopsy to support or confirm the diagnosis [7][8].

Once diagnosed, management centers on a two-stage strategy designed to protect brain tissue and prevent future damage. The initial “induction” phase uses aggressive medications to quickly halt the inflammatory attack, followed by a much longer “maintenance” phase intended to keep the immune system stable [9][10]. Treatment of secondary disease may require additionally treating the underlying autoimmune illness, infection, cancer, or medication trigger. Because PACNS carries a significant risk of relapse, this maintenance phase often lasts for years, requiring consistent follow-up and regular imaging to ensure the disease remains in remission [11][12]. While the treatment and monitoring required for PACNS are intensive, they are part of a structured path aimed at stabilizing your neurological health and helping you navigate life with a chronic but treatable condition [7].

Common questions in this guide

What is CNS vasculitis, and what does PACNS mean?
CNS vasculitis is inflammation of blood vessels in the brain and spinal cord. PACNS, or primary angiitis of the central nervous system, is the form in which the suspected immune attack is limited to those neurological blood vessels; secondary CNS vasculitis is linked to another illness or trigger.
What symptoms can CNS vasculitis cause?
Symptoms can develop gradually or appear suddenly. They may include persistent headaches, cognitive changes or brain fog, sudden weakness, and difficulty speaking that can resemble a stroke.
What tests are used to diagnose CNS vasculitis?
Doctors usually use several tests together, including MRI scans and spinal fluid analysis. Depending on the case, catheter angiography or a brain biopsy may provide additional evidence or help confirm the diagnosis.
How is PACNS treated?
Treatment generally has an induction phase and a maintenance phase. Induction uses aggressive medicines to stop active inflammation quickly, while maintenance uses longer-term medication to keep the immune system stable. If vasculitis is secondary, care also addresses the underlying autoimmune illness, infection, cancer, or medication trigger.
How long does treatment for PACNS usually last?
The maintenance phase often lasts for years because PACNS can relapse. The care team determines when to move from induction to maintenance based on the individual situation and follow-up findings, so patients should discuss the transition with their neurologist and rheumatologist.
Why is coordination between specialists important for CNS vasculitis?
CNS vasculitis is rare and may require neurological monitoring as well as evaluation or treatment of an underlying illness. Coordinating a neurologist, rheumatologist, and primary care doctor can help keep testing, medicines, and follow-up aligned.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with PACNS are currently being managed at this center?
  2. 2.Is there a single person on my care team—such as a nurse coordinator or specialized neurologist—who will be my primary point of contact for day-to-day questions?
  3. 3.What is the specific plan for collaborating between my neurologist, rheumatologist, and primary care doctor?
  4. 4.How will we determine when I have successfully transitioned from the 'induction' phase to 'maintenance' therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Central Nervous System Vasculitis: Primary Angiitis of the Central Nervous System and Central Nervous System Manifestations of Systemic Vasculitis.

    Amin M, Uchino K, Hajj-Ali RA

    Rheumatic diseases clinics of North America 2023; (49(3)):603-616 doi:10.1016/j.rdc.2023.03.011.

    PMID: 37331735
  2. 2

    Overview of Primary Angiitis of the Central Nervous System: Current Insights.

    Phu A, Agrawal DK

    Archives of internal medicine research 2026; (9(1)):40-52 doi:10.26502/aimr.0236.

    PMID: 41947889
  3. 3

    "I'm not feeling alone in my experiences": How newly diagnosed autistic adults engage with a neurodiversity-affirming "Welcome Pack".

    Edwards C, Love AM, Cai RY, et al.

    Autism : the international journal of research and practice 2025; (29(8)):2072-2083 doi:10.1177/13623613251335070.

    PMID: 40277162
  4. 4

    Outcomes among patients with primary angiitis of the CNS: A Nationwide United States analysis.

    Patel SD, Oliver FO, Elmashad A, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022; (31(11)):106747 doi:10.1016/j.jstrokecerebrovasdis.2022.106747.

    PMID: 36162376
  5. 5

    Primary central nervous system vasculitis - An update on diagnosis, differential diagnosis and treatment.

    Kraemer M, Berlit P

    Journal of the neurological sciences 2021; (424()):117422 doi:10.1016/j.jns.2021.117422.

    PMID: 33832773
  6. 6

    Subtypes of primary angiitis of the CNS identified by MRI patterns reflect the size of affected vessels.

    Schuster S, Bachmann H, Thom V, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(9)):749-755 doi:10.1136/jnnp-2017-315691.

    PMID: 28705900
  7. 7

    European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS).

    Pascarella R, Antonenko K, Boulouis G, et al.

    European stroke journal 2023; (8(4)):842-879 doi:10.1177/23969873231190431.

    PMID: 37903069
  8. 8

    Primary Angiitis of the Central Nervous System and Its Mimics: A Pattern-Based Approach to Biopsies for Central Nervous System Vasculitis.

    Cecchi R, Becker N, Conway KS

    Archives of pathology & laboratory medicine 2025; (149(10)):e315-e322 doi:10.5858/arpa.2024-0286-RA.

    PMID: 40079061
  9. 9

    Diagnosis and management of adult primary angiitis of the central nervous system: an international survey on current practices.

    Nehme A, Lanthier S, Boulanger M, et al.

    Journal of neurology 2023; (270(4)):1989-1998 doi:10.1007/s00415-022-11528-7.

    PMID: 36538155
  10. 10

    Diagnostic and therapeutic approach to adult central nervous system vasculitis.

    Nehme A, Boulanger M, Aouba A, et al.

    Revue neurologique 2022; (178(10)):1041-1054 doi:10.1016/j.neurol.2022.05.003.

    PMID: 36156251
  11. 11

    Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System-A Multicenter Cohort Study in 163 Patients.

    Fisse AL, Bonberg N, Beuker C, et al.

    Annals of neurology 2025; (98(4)):883-893 doi:10.1002/ana.27295.

    PMID: 40546217
  12. 12

    Treatment and Long-Term Outcomes of Primary Central Nervous System Vasculitis.

    de Boysson H, Arquizan C, Touzé E, et al.

    Stroke 2018; (49(8)):1946-1952 doi:10.1161/STROKEAHA.118.021878.

    PMID: 29986936

This page is for informational purposes only and does not constitute medical advice. Your neurologist and rheumatologist can interpret your symptoms and create a treatment and monitoring plan for your situation.

Get notified when new evidence is published on central nervous system vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.